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ABSTRACT
Surveillance is usually deﬁned as the ongoing and systematic collection, analysis and interpretation of
health data essential to the planning, implementation and evaluation of public health practice. During
recent years, most of these programmes have been developed in the ﬁeld of antimicrobial resistance and
nosocomial infections, but efforts have also been made in other areas. Recent experiences of emerging
microbial threats, including severe acute respiratory syndrome and new inﬂuenza variants affecting
humans, the re-emergence of infectious disease problems and the possibility of bioterrorism have
evidenced the need for implementation of infectious disease surveillance programmes. Clinical
microbiology laboratories play a pivotal role in these programmes. They have the ﬁrst opportunity to
detect these problems and should participate in the design of reporting strategies and dissemination of
this information. Policies for the ﬂow of data to national and international authorities should be
established using passive surveillance strategies. However, active surveillance programmes taking
advantage of new methodologies, including virtual tools and mathematical programs, should be the
goal for early detection of unusual patterns of microbial pathogens, outbreaks and healthcare-associated
infections. In addition, early implementation of response strategies should be designed and performed
with the cooperation of microbiology laboratories, and intervention and response protocols should be
deﬁned with the participation of clinical microbiologists.
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INTRODUCTION
Surveillance is commonly deﬁned as the ‘ongo-
ing and systematic collection, analysis and
interpretation of health data essential to the
planning, implementation, and evaluation of
public health practice, closely integrated with
timely dissemination of these data to those who
need to know; the ﬁnal link of the surveillance
chain being the application of these data to the
control and prevention of human disease and
injury’ [1,2]. During recent years, most of these
programmes in the area of infectious diseases
have been developed in the ﬁeld of antimicro-
bial resistance and nosocomial infections, but
efforts have also been made in other areas [3].
A non-exhaustive list of areas of interest and
research in infectious disease surveillance is
presented in Table 1.
The clear importance of the participation of
clinical microbiology laboratories and microbiol-
ogists has been established in resistance and
infection surveillance programmes and has been
considered as a model for other areas of research
[4]. These ﬁelds represent an opportunity for the
implementation of microbiology techniques and
research projects [5,6]. Interestingly, in resistance
and nosocomial surveillance programmes, micro-
biologists are widely accepted and integrated into
the core decision and control teams. Moreover,
these programmes provide an example of effec-
tive feedback, achieved by the participation and
integration of professionals.
Different publications address the importance
of the microbiologist and laboratories in infection
and antimicrobial resistance control programmes
in the nosocomial setting [5, 7–9]. More recently,
this experience has been applied to community-
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acquired infections, and several surveillance
programmes have been implemented [10]. In
these programmes, quantiﬁcation of resistance is
commonly used for guidance in antimicrobial use,
research and education programmes, and design
of intervention strategies for the control of anti-
microbial resistance, and this also has a clear
impact on new antimicrobial development and
licensing strategies. In all these programmes,
microbiologists are essential partners. It has been
recommended that this experience be applied to
other areas of infectious disease surveillance.
Recent experience of emerging microbial
threats, including the severe acute respiratory
syndrome (SARS) and new inﬂuenza A virus
variants affecting humans, the re-emergence of
infectious disease problems and the possibility
of bioterrorism have demonstrated the need for
implementation of infectious disease surveil-
lance programmes. Clinical microbiology labor-
atories play a pivotal role in these programmes,
as they are ﬁrst in line for the detection of
emerging problems and consequently should
participate in the design of reporting strategies,
dissemination of information and intervention
programmes.
MICROBIOLOGY LABORATORY:
TOWARDS A NEW SCENARIO?
In the last decade, new organisational models for
microbiology laboratories have emerged, due to
drastic changes in healthcare systems and the
emergence of microbial threats in infectious dis-
eases. The former have been deeply analysed [11]
and are related to changes in patient demograph-
ics, technical developments and changes in the
workforce. In addition, the objective of healthcare
cost containment has had a drastic inﬂuence on
this situation [12,13]. As a result, most microbio-
logy laboratories have changed their organisa-
tional structures or may be required to do so in
the near future. Externalisation of the microbio-
logy assistance in central laboratories belonging
to the private sector has been accomplished in
some countries [14]. Also, consolidation is an
attractive way for microbiology laboratory survi-
val [14]. In some cases, routine microbiology
processes such as serology or urine screening
are concentrated in a core laboratory, which can
provide a rapid-response at a low cost. Most of
these core laboratories have emerged from bio-
chemistry and haematology laboratories, due to
the necessity of incorporating automatable pro-
cesses in a rapid-response and cost-effective
structure. Redundant instruments capable of
multiple analyses are eliminated, and those
remaining are concentrated in a core laboratory.
Nowadays, core laboratories, including microbio-
logy and immunology processes, have a horizon-
tal organisational model (Fig. 1). Theoretically,
with this organisation, microbiology processes
are under the supervision of senior clinical micro-
biologists. An inherent advantage is that non-
repetitive microbiology techniques can be
developed in speciﬁc microbiology laboratories.
This may consolidate microbiology laboratories.
They can improve techniques in the ﬁeld, inclu-
ding molecular techniques, implementing tradi-
tional microbiology-based techniques, and
restoring the consultation role of the clinical
microbiologist [13]. This has led to the active
participation of microbiologists in nosocomial
Table 1. Areas of interest and research in infectious
disease surveillance
Antimicrobial resistance and multiresistant pathogens
Food-borne and water-borne diseases
Vector-borne and zoonotic diseases
Chronic diseases caused by infectious agents
Diseases transmitted through blood transfusions
Vaccination and consequences of infecting agents
Diseases of pregnant women and newborns
Diseases of travellers, immigrants and refugees
Terrorism-associated infectious disease pathogens
New emerging and re-emerging pathogens
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Fig. 1. Core laboratory structure with a horizontal model
organization. Automation systems, technologies, manage-
ment of patient samples. Quality control protocols are
common but supervision of the results is performed by
different staff.
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infection management. In some European
countries, microbiologists are considered essential
for the control of nosocomial infections. Micro-
biology surveillance studies, educational inter-
ventions, recommendations for the control of
nosocomial infection, audits and feedback initia-
tives are developed with the active participation
of the microbiologist.
It is worth noting that organisational models
of microbiology laboratories may drastically
affect infectious disease surveillance. The emer-
gence of West Nile viruses in the USA has
shown the need for the maintenance and revi-
talisation of microbiology laboratories [14]. The
experience gained with emerging viral infections,
including Ebola and inﬂuenza A viruses, and
particularly with SARS, has revealed that micro-
biology laboratories might act as sentinels of
emerging infectious disease threats [16]. Rapid
alert to outbreak situations may be accelerated
with microbiology laboratories integrated into
national and supra-national global surveillance
programmes. Open cooperation with inter-
national networks has been essential for the
design of control strategies. In addition, the
application of new molecular diagnostic tech-
niques and the involvement of basic research
microbiology laboratories have been effective in
resolving new microbiological threats (e.g., the
SARS experience).
ALERT AND RESPONSE OF
MICROBIOLOGY LABORATORIES IN
INFECTIOUS DISEASE
SURVEILLANCE PROGRAMMES
The alert and response of microbiology laborat-
ories in infectious disease surveillance pro-
grammes should be performed with the
implementation of natural workﬂows in micro-
biology laboratories. Some of these processes can
be developed in cooperation with research labor-
atories if this activity is not integrated in the same
laboratory (Fig. 2). Natural workﬂow of micro-
biology laboratory includes: (1) specimen man-
agement, (2) specimen processing (methods), and
(3) results and data ﬂow.
Specimen management
Specimen management is essential for accurate
work in the clinical laboratory. It has been
recognised that appropriate collection and hand-
ling are essential for the diagnosis of infectious
diseases and also for infectious disease surveil-
lance [17]. Specimen selection criteria, collection
procedures, labelling, transport conditions and
storage criteria should be established with the
participation of the clinical microbiologist. All
these processes should be performed under
adequate biosafety conditions capable of protect-
ing laboratory workers.
Nowadays, transport of biological material to
different laboratories or from healthcare facilities
to a laboratory is a common feature of healthcare
systems. Moreover, in infectious disease sur-
veillance networks, transportation of biological
samples, including patients’ material and viable
microorganisms,toacentral laboratoryisacommon
practice. These materials should be adequately
packed, not only to protect transport handlers,
but also to prevent specimen deterioration and
avoid the spread of infectious agents. In addition,
labelling should be performed according to
national and international regulations. Although
these processes are bureaucratic and time-consu-
ming, microbiologists should be familiar with
these procedures, particularly when samples are
sent for processing in a central laboratory.
Specimen processing and methods
Microbiology laboratories must implement rapid
techniques, including immunoassay, microscopy
and molecular testing [13]. New molecular meth-
ods have been developed during the last two
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Fig. 2. Work ﬂow of microbiology laboratories, integration
of research laboratories and processes that can be imple-
mented for infectious diseases surveillance in these labor-
atories.
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decades and have recently been introduced in
clinical laboratories as a consequence of automa-
tion and the development of techniques that are
easier to perform. Clinical microbiologists should
become familiar with molecular techniques and
incorporate these in the normal microbiology
routine. The introduction of rapid response in
some laboratory areas has demonstrated clinical
and economic beneﬁts for healthcare systems,
particularly in antimicrobial susceptibility testing
and virology [18,19].
Molecular techniques have had a direct impact
on rapid response and infectious disease surveil-
lance. They have been shown to be essential for the
identiﬁcation of emerging pathogens and for
understanding their population structure. They
are also useful for characterising virulence deter-
minants and the genes participating in antimicro-
bial resistance. During outbreaks, they are essential
tools for tracking the spread of microbial patho-
gens and for evaluation of intervention strategies
[6,20]. The results of a large number of researchers
have shown the advantages of molecular tech-
niques in infectious disease surveillance, including
local studies and international networks, not only
in the nosocomial setting but also in the commu-
nity.Molecular techniques also have the advantage
of being useful for researching genetic determi-
nantswithout culturing organisms, thus allowing a
more rapid laboratory response.
Results and data management
Most of the infectious disease surveillance net-
works have based their strategies on the manage-
ment of results generated by microbiology
laboratories [21–23]. The different experiences at
local and international levels have increased the
efﬁciency of this process. The clinical laboratory
should ensure sufﬁcient internal data manage-
ment resources and a substantial database storage
capacity, as well as adequately developed
computing equipment and protocols. Internal
microbiology software should permit the auto-
matic alert of unusual results, and detection of
increased trends and accumulation of cases. These
systems must be ﬂexible and accessible to other
computing systems in order that microbiology
data can be integrated in regional, national and
international databases. Again, experience in this
area is based on resistance surveillance with the
active participation of microbiologists.
ROLE OF THE MICROBIOLOGIST
AND CLINICAL MICROBIOLOGY
LABORATORIES IN PASSIVE,
ACTIVE AND VIRTUAL
SURVEILLANCE
Surveillance programmes have made apparent
the importance of microbiology laboratories for
public health action in infectious diseases [24].
The strategies of traditional systems (passive
surveillance), which have been used on national
and international levels, were based on detecting
problems through the systematic routine analysis
of all microbiological data. These systems are
time-consuming and do not require personnel
trained in infectious diseases or infection control.
Alert is commonly performed with a paper-based
system and requires a prolonged period of time
for response.
The alternative to passive surveillance is the
active surveillance system, which targets
infectious disease problems and thresholds that
have been previously established. Trained pro-
fessionals, including clinical microbiologists and
epidemiologists, actively participate in surveil-
lance, and information is more rapidly proc-
essed. Recently, there has been an increase in
international use of sentinel laboratories to
improve upon traditional systems [23]; unre-
ported infectious disease problems have been
detected, and additional information obtained
by global surveillance networks has been pro-
vided.
Active surveillance systems are now augmen-
ted by the inclusion of new computing technol-
ogies and the use of mathematical models. This
novel strategy, also called ‘virtual surveillance’, is
one of the most attractive options to optimise
available laboratory information and can be
developed with the active participation of specif-
ically trained clinical microbiologists to provide
real-time information. Nowadays, virtual surveil-
lance should be the goal for early detection of
unusual patterns of microbial pathogens and
healthcare-associated infections [25].
Recent experience has demonstrated the advan-
tages of surveillance systems that employ elec-
tronic laboratory-based reporting systems. They
are frequently promoted to improve data quality
and efﬁciency of collection, but they are essential
for outbreak detection. In this sense, the availab-
ility of internet access permits rapid feedback and
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even interactive interventions for the exchange of
interpretation and action plans. In the Pennsyl-
vania experience, which covered a large popula-
tion area [20], several laboratories implemented
their computing systems and connected them to
the regional healthcare electronic information
system. Automatic reporting was found to be
more effective than the conventional system,
reducing the time needed for a paper-based
report (median, 5 days), to a median of 1 day
for an electronic report. Similar systems have now
been developed in some European countries [22].
Features include the use of a ﬂexible algorithm for
daily analysis of data and presentation of signals
on the internet for interpretation by health profes-
sionals. These systems are designed to comple-
ment, but not replace, conventional methods, as
they receive reports from sources other than
laboratories (e.g., clinician-based surveillance of
notiﬁable diseases). Electronic ⁄ laboratory-based
surveillance will allow early implementation of
response and control strategies. Moreover, elec-
tronic reporting is highly sensitive and speciﬁc,
with a low rate of false-positive and false-negative
results.
ADVANTAGES OF MICROBIOLOGY
LABORATORY PARTICIPATION IN
INFECTIOUS DISEASE
SURVEILLANCE
The participation of routine microbiology labor-
atories in surveillance has clear advantages for
infectious disease surveillance. Technical meth-
odologies and reporting of results can lead to
better analysis, and all the information can be
centralised, particularly when laboratory compu-
ting systems are connected to regional, national
and supra-national systems. Automatic ‘expert
systems’ can thus be developed to augment the
analysis of surveillance data, and automatic alerts
can be centralised for response strategies. Micro-
biology laboratories and microbiology resources
may also facilitate temporal and spatial analysis
of surveillance data, which would ensure the
complete collection of notiﬁable diseases, as well
as the detection of changing patterns.
CONCLUSION
In conclusion, infectious disease surveillance
requires the active participation of microbiology
laboratories, in which new methodologies and
robust information technologies should be imple-
mented in order to guarantee early detection of
outbreaks. Early response strategies should be
designed with the cooperation of microbiology
laboratories, in which the efforts of clinical and
research microbiologists should be coordinated.
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